Search results for "High sensitivity troponin"

showing 4 items of 4 documents

Undetectable high-sensitivity troponin in combination with clinical assessment for risk stratification of patients with chest pain and normal troponi…

2020

Background Undetectable high-sensitivity cardiac troponin (hs-cTn) in a single determination upon admission may rule out acute coronary syndrome. We investigated undetectable hs-cTnT (<detection limit; <5 ng/l) together with clinical risk scores (GRACE, TIMI, HEART and a previously published simple score), for one-year outcomes in patients with chest pain and normal hs-cTnT (<99th percentile; <14 ng/l) upon admission. Methods This study was a retrospective design involving 2254 consecutive patients (July 2016–November 2017). The primary endpoint was one-year death or acute myocardial infarction; the secondary endpoint added unstable angina requiring revasculariz…

MaleChest PainAcute coronary syndromemedicine.medical_specialtyCardiac troponinmedicine.medical_treatment030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineChest painRevascularizationRisk Assessment03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicinemedicineHumans030212 general & internal medicineRetrospective StudiesInpatientsbiologybusiness.industryUnstable anginaGeneral MedicineMiddle AgedPrognosismedicine.diseaseTroponinTroponinHigh sensitivity troponinRisk stratificationbiology.proteinCardiologyFemalemedicine.symptomEmergency Service HospitalCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean Heart Journal. Acute Cardiovascular Care
researchProduct

High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism

2020

While numerous studies have confirmed the prognostic role of high-sensitivity troponin T (hsTnT) in pulmonary embolism (PE), high-sensitivity troponin I (hsTnI) is inappropriately studied. This study aimed to investigate the prognostic relevance of hsTnI in normotensive PE, establish the optimal cut-off value for risk stratification and to compare the prognostic performances of hsTnI and hsTnT. Based on data from 459 consecutive PE patients enrolled in a single-centre registry, receiver operating characteristic analysis was used to identify an optimal hsTnI cut-off value for prediction of in-hospital adverse outcomes (PE-related death, cardiopulmonary resuscitation or vasopressor treatment)…

Pulmonary and Respiratory Medicine7medicine.medical_specialtymedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineTroponin Imedicine030212 general & internal medicineCardiopulmonary resuscitationPulmonary Vascular DiseaseTroponin Tbusiness.industrylcsh:ROdds ratioOriginal Articlesmedicine.diseaseConfidence intervalPulmonary embolismHigh sensitivity troponinRisk stratificationCardiologybusinessERJ Open Research
researchProduct

P1193Prognostic value of high sensitive troponin I in patients with atrial fibrillation in the emergency department

2018

medicine.medical_specialtybusiness.industryAtrial fibrillationEmergency departmentmedicine.diseasePhysiology (medical)Internal medicineHigh sensitivity troponinTroponin ImedicineCardiologyIn patientCardiology and Cardiovascular MedicinebusinessValue (mathematics)EP Europace
researchProduct

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2020

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

unstable anginaMyocardial ischaemia[SDV]Life Sciences [q-bio]Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]dual antithrombotic therapyGuidelineheparin030204 cardiovascular system & hematologyPlatelet inhibitionantiplatelet0302 clinical medicineST segmentMedicinedabigatranMyocardial infarctionguidelinesglycoprotein iib/iiia inhibitorsanticoagulationNon-ST Elevated Myocardial InfarctionrivaroxabanComputingMilieux_MISCELLANEOUSreproductive and urinary physiologydiabetesbleedingsbivalirudinatherothrombosiDisease ManagementangioplastyGuidelines • acute cardiac care • acute coronary syndrome • angioplasty • anticoagulation • antiplatelet • apixaban • aspirin • atherothrombosis • betablockers • bleedings • bivalirudin • bypass surgery • cangrelor • chest pain unit • clopidogrel • dabigatran • diabetes • dual antithrombotic therapy • early invasive strategy • edoxaban • enoxaparin • European Society of Cardiology • fondaparinux • glycoprotein IIb/ IIIa inhibitors • heparin • high-sensitivity troponin • minoca • myocardial ischaemia • myocardial infarction • nitrates • non-ST-elevation myocardial infarction • platelet inhibition • prasugrel • recommendations • revascularization • rhythm monitoring • rivaroxaban • stent • ticagrelor • triple therapy • unstable anginaenoxaparinGeneral MedicineClopidogrel3. Good healthearly invasive strategymyocardial infarctiontriple therapy030220 oncology & carcinogenesisHigh sensitivity troponinembryonic structuresCardiologyPlatelet aggregation inhibitorrevascularizationbiological phenomena cell phenomena and immunityCardiology and Cardiovascular MedicineTicagrelormedicine.drugHumanrecommendationAcute coronary syndromemedicine.medical_specialtyaspiringlycoprotein IIb/IIIa inhibitornon-ST-elevation myocardial infarctionapixabanrhythm monitoringEuropean Society of Cardiologyticagrelor03 medical and health sciencesnitrateatherothrombosisbetablockersInternal medicineacute cardiac careminocachest pain unitDiseases of the circulatory (Cardiovascular) systemHumansIn patientAcute Coronary SyndromeclopidogrelUnstable anginaurogenital systemnitratesbusiness.industryfondaparinuxbetablockerArrhythmias Cardiac030229 sport sciencesbleedingmedicine.diseasemyocardial ischaemiaplatelet inhibitionprasugreldiabeteGlycoprotein IIb/IIIa inhibitorsRC666-701bypass surgerySettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARErecommendationsedoxabanhigh-sensitivity troponinstentbusinessPlatelet Aggregation Inhibitorscangrelor
researchProduct